Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Gap Inc V.GAP


Primary Symbol: GAP

The Gap, Inc. is a specialty apparel company in America. The Company offers apparel, accessories and personal care products for women, men and children. Its Old Navy, Gap, Banana Republic, and Athleta brands offer clothing, accessories and lifestyle products for men, women and children. It is an omni-channel retailer, with sales to customers both in stores and online, through Company-operated and franchise stores, websites, and third-party arrangements. Its omni-channel services, including buying online pick-up in store, order-in-store, find-in-store, and ship-from-store, as well as enhanced mobile-enabled experiences, are tailored across its collection of brands. Gap includes adult apparel and accessories, GapKids, babyGap, Gap Maternity, GapBody, and GapFit collections. Banana Republic is a premium lifestyle retailer celebrating exploration and self-expression through timeless quality, versatile fabrics, and exceptionally made womenswear, menswear, and home designs.


NYSE:GAP - Post by User

Bullboard Posts
Comment by unevenon Sep 16, 2009 9:12pm
182 Views
Post# 16312986

RE: testing timeline example

RE: testing timeline exampleJust to add my 2 cents I think alot has changed since 1993 for one thing the baby boomers are 15 years older and cancer is taking a larger toll. I think (hope) that after the 5 dose if someone like Dr. Brian Druker with a proven track record takes notice of GAP107B8 then the path will be paved to human trials given the previous in house testing on mice. I think that there will be a number of NCI centres specializing in a number of different cancers wanting to take the baton so to speak so look at the news flow of the last three months and multiply that out and add to that the attention south of the border. A Nasdaq listing would fit right in.
Bullboard Posts